After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a ...

Of course, the health risks of too much sunlight are well-known and include skin cancer, immune system suppression, and vision-damaging eye conditions like cataracts and macular degeneration. The key ...

Dyne announced the results of new analyses of cardiac and pulmonary function amongst all DELIVER participants who were randomized to z-rostudirsen treatment at baseline (any dose 1) and for whom ...

Pratteln, Switzerland, February 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE® ...

When closely related species mate, their offspring sometimes survive but cannot reproduce. This pattern often affects males ...

​​The new model is expected to retain the existing 2.8-litre four-cylinder turbo-diesel engine, paired with either a ...

Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Team IMPACT partnerships often last long beyond the 2-year contract between children and the teams that sign them.

HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 -- 48-week trial will enroll approximately 150 ...

Pratteln, Switzerland, February 27, 2026 - Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE (va ...